149 related articles for article (PubMed ID: 10962741)
1. Influence of propafenone on resetting and termination of canine atrial flutter.
Mensour B; Jalil E; Vinet A; Kus T
Pacing Clin Electrophysiol; 2000 Aug; 23(8):1200-19. PubMed ID: 10962741
[TBL] [Abstract][Full Text] [Related]
2. Effects of procainamide and propafenone on the composition of the excitable gap in canine atrial reentry tachycardia.
Derakhchan K; Pagé P; Lambert C; Kus T
J Pharmacol Exp Ther; 1994 Jul; 270(1):47-54. PubMed ID: 8035342
[TBL] [Abstract][Full Text] [Related]
3. Effects of procainamide on the excitable gap composition in a canine model of atrial flutter.
Jalil E; Laflamme M; Kus T
Can J Physiol Pharmacol; 1997 Jan; 75(1):1-8. PubMed ID: 9101058
[TBL] [Abstract][Full Text] [Related]
4. Effects of pentisomide and E-4031 on canine atrial flutter due to reentry: a comparative study with disopyramide and propafenone.
Inoue H; Yamashita T; Usui M; Nozaki A; Saihara S; Sugimoto T
J Cardiovasc Pharmacol; 1991 Jul; 18(1):137-43. PubMed ID: 1719282
[TBL] [Abstract][Full Text] [Related]
5. Termination of Atrial Flutter and Fibrillation by K201's Metabolite M-II: Studies in the Canine Sterile Pericarditis Model.
Sadrpour SA; Serhal M; Khrestian CM; Lee S; Fields T; Dittrich HC; Waldo AL
J Cardiovasc Pharmacol; 2015 May; 65(5):494-9. PubMed ID: 25636078
[TBL] [Abstract][Full Text] [Related]
6. Electropharmacologic effects of class I and class III antiarrhythmia drugs on typical atrial flutter: insights into the mechanism of termination.
Tai CT; Chen SA; Feng AN; Yu WC; Chen YJ; Chang MS
Circulation; 1998 May; 97(19):1935-45. PubMed ID: 9609087
[TBL] [Abstract][Full Text] [Related]
7. Effects of antiarrhythmic drugs on canine atrial flutter due to reentry: role of prolongation of refractory period and depression of conduction to excitable gap.
Inoue H; Yamashita T; Nozaki A; Sugimoto T
J Am Coll Cardiol; 1991 Oct; 18(4):1098-104. PubMed ID: 1910060
[TBL] [Abstract][Full Text] [Related]
8. Effects of procainamide on refractoriness, conduction, and excitable gap in canine atrial reentrant tachycardia.
Kus T; Derakhchan K; Bouchard C; Pagé P
Pacing Clin Electrophysiol; 1991 Nov; 14(11 Pt 2):1707-13. PubMed ID: 1721162
[TBL] [Abstract][Full Text] [Related]
9. Ranolazine terminates atrial flutter and fibrillation in a canine model.
Bhimani AA; Yasuda T; Sadrpour SA; Khrestian CM; Lee S; Zeng D; Belardinelli L; Waldo AL
Heart Rhythm; 2014 Sep; 11(9):1592-9. PubMed ID: 25066042
[TBL] [Abstract][Full Text] [Related]
10. Atrial flutter termination by overdrive transesophageal pacing and the facilitating effect of oral propafenone.
Doni F; Della Bella P; Kheir A; Manfredi M; Piemonti C; Staffiere E; Rimondini A; Fiorentini C
Am J Cardiol; 1995 Dec; 76(17):1243-6. PubMed ID: 7503004
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of spontaneous termination of stable atrial flutter in the canine sterile pericarditis model.
Ortiz J; Igarashi M; Gonzalez HX; Laurita K; Rudy Y; Waldo AL
Circulation; 1993 Oct; 88(4 Pt 1):1866-77. PubMed ID: 8403332
[TBL] [Abstract][Full Text] [Related]
12. Azd7009: a new antiarrhythmic drug with predominant effects on the atria effectively terminates and prevents reinduction of atrial fibrillation and flutter in the sterile pericarditis model.
Goldstein RN; Khrestian C; Carlsson L; Waldo AL
J Cardiovasc Electrophysiol; 2004 Dec; 15(12):1444-50. PubMed ID: 15610294
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of double potentials recorded during sustained atrial flutter in the canine right atrial crush-injury model.
Feld GK; Shahandeh-Rad F
Circulation; 1992 Aug; 86(2):628-41. PubMed ID: 1638727
[TBL] [Abstract][Full Text] [Related]
14. The gap junction modifier, GAP-134 [(2S,4R)-1-(2-aminoacetyl)-4-benzamido-pyrrolidine-2-carboxylic acid], improves conduction and reduces atrial fibrillation/flutter in the canine sterile pericarditis model.
Rossman EI; Liu K; Morgan GA; Swillo RE; Krueger JA; Gardell SJ; Butera J; Gruver M; Kantrowitz J; Feldman HS; Petersen JS; Haugan K; Hennan JK
J Pharmacol Exp Ther; 2009 Jun; 329(3):1127-33. PubMed ID: 19252062
[TBL] [Abstract][Full Text] [Related]
15. Activation patterns in experimental canine atrial flutter produced by right atrial crush injury.
Feld GK; Shahandeh-Rad F
J Am Coll Cardiol; 1992 Aug; 20(2):441-51. PubMed ID: 1634684
[TBL] [Abstract][Full Text] [Related]
16. Atrial-selective sodium channel block strategy to suppress atrial fibrillation: ranolazine versus propafenone.
Burashnikov A; Belardinelli L; Antzelevitch C
J Pharmacol Exp Ther; 2012 Jan; 340(1):161-8. PubMed ID: 22005044
[TBL] [Abstract][Full Text] [Related]
17. Electrophysiological response of the right atrium to ibutilide during typical atrial flutter.
Cheng J; Glatter K; Yang Y; Zhang S; Lee R; Scheinman MM
Circulation; 2002 Aug; 106(7):814-9. PubMed ID: 12176953
[TBL] [Abstract][Full Text] [Related]
18. Pharmacologic alterations in human type I atrial flutter cycle length and monophasic action potential duration. Evidence of a fully excitable gap in the reentrant circuit.
Stambler BS; Wood MA; Ellenbogen KA
J Am Coll Cardiol; 1996 Feb; 27(2):453-61. PubMed ID: 8557920
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of KCB-328, a new IKr blocking antiarrhythmic agent in pacing induced canine atrial fibrillation.
Chandra P; Rosen TS; Yeom ZH; Lee K; Kim HY; Danilo P; Rosen MR
Europace; 2004 Sep; 6(5):384-91. PubMed ID: 15294262
[TBL] [Abstract][Full Text] [Related]
20. Transitions among atrial fibrillation, atrial flutter, and sinus rhythm during procainamide infusion and vagal stimulation in dogs with sterile pericarditis.
Pagé PL; Hassanalizadeh H; Cardinal R
Can J Physiol Pharmacol; 1991 Jan; 69(1):15-24. PubMed ID: 2036596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
